Pure Global AI
NCT06292052Recruiting

Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness

Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness: A Retrospective Multi-institutional Cohort Analysis
Sun Yat-sen UniversityClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Lung Cancer
Drug/Device/Intervention
Immunotherapy
Study type
Observational
Intervention type
drug
Sponsor & location
Primary sponsor
Sun Yat-sen University
Location
Guangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2017
End date
Apr 01, 2024
Enrollment
350 participants
Primary outcome

Complete pathologic response

Summary

The goal of this retrospective cohort analysis is to discover the impact of the involvement
 extent of tumor-draining lymph nodes (TDLNs) in patients who received neoadjuvant
 immunochemotherapy. The main question it aims to answer is the role of TDLN in the prediction
 of treatment effectiveness. Researches will compare tumor-draining lymph nodes metastasis
 (mTDLNs) group and non-draining lymph nodes metastasis (mNDLNs) group to see whether
 different metastatic patterns of mediastinal lymph nodes can indicate the treatment
 effectiveness.

ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06292052
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06292052 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Recruiting. The study focuses on Lung Cancer. Target enrollment is 350 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.